Proprietary pain relief cream formulations
Commercial- Indications
- Pain
Company intelligence / Profile preview
Transdermal Therapeutics
Birmingham, Alabama, United Statestransdermalinc.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Transdermal Therapeutics specializes in compounding topical pain relief medications using a proprietary micelle formation process that targets nociceptors to prevent them from firing, providing pain relief without the risk of addiction or overdose associated with oral pain medications.
- Therapeutic areas
- Neurology
- Modalities
- Topical pain medicationscompounded formulations
- Industry
- Non-Academic Healthcare
02
Drug pipeline
1 asset03
Partnerships
Partnerships with the medical community for research and discovery of pain solutions[4]
Beyond the preview
Go deeper on Transdermal Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transdermal Therapeutics.